Kidney function and potassium monitoring after initiation of renin-angiotensin-aldosterone system blockade therapy and outcomes in two North American populations.

BACKGROUND: Clinical practice guidelines recommend routine kidney function and serum potassium testing within 30 days of initiating angiotensin-converting enzyme inhibitor (ACEi) or angiotensin II receptor blocker (ARB) therapy. However, evidence is lacking about whether follow-up testing reduces th...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Circ Cardiovasc Qual Outcomes
Asıl Yazarlar: Parikh, Rishi V, Nash, Danielle M, Brimble, K Scott, Markle-Reid, Maureen, Tan, Thida C, McArthur, Eric, Khoshniat-Rad, Farzien, Sood, Manish M, Zheng, Sijie, Pravoverov, Leonid, Nesrallah, Gihad E, Garg, Amit X, Go, Alan S
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7717925/
https://ncbi.nlm.nih.gov/pubmed/32873054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCOUTCOMES.119.006415
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller